PharmaLive

Lilly Eyes More Cancer Deals, But Wary Of CAR-T, Gene Therapy

Teva, Amgen End Dispute Over Generic Cinacalcet HCl Tablets

Mylan To Recall All Batches Of Blood Pressure Medicine Valsartan In U.S.

Ironwood, Allergan Announce Settlement With Mylan Resolving Linzess Patent Litigation

AstraZeneca Lays Off 210 In Colorado Amidst Restructuring, Executives Changes

J&J Raises U.S. Prices On Around Two Dozen Drugs

Class Action Lawsuit Aims To Halt GSK Acquisition Of Tesaro

AbbVie’s Rova-T Sees Another Failure, Casts Doubt On Multi-Billion-Dollar Acquisition

U.S. FDA Clears New Protocol For Study On Bayer's Birth Control Device

Sanofi To Pay Regeneron $462 Million In Revised Immuno-Oncology Deal

Gilead Inks $785 Million Deal With Yuhan For NASH Development

Roche's Lung Cancer Combo Treatment Wins FDA Approval

Takeda Drives Immuno-Oncology Portfolio With Three Cell Therapy Collaborations

Astellas Breaks Into U.S. Blood Cancer Market With Approval Of Xospata For AML

Ireland Demands $1.9 Billion In Back Taxes From Perrigo

Alexion Wins Early U.S. Approval For Rare Blood Disorder Drug

Merck Loses Bid To Revive $200 Million Gilead Verdict At U.S. High Court

Leadership representing the 2018 Manny Award agency/network winners and finalists share their views on various healthcare industry trends and developments.

Novartis’ Crizanlizumab Receives FDA Breakthrough Therapy Designation

Bristol-Myers Bulks Up With $74 Billion Deal To Buy Celgene